CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
Numbers of patients, length of follow-up keep growing with no visible downside (yet)
Source: medpagetoday.com
📰 Greg Deener News
Greg Deener News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Greg Deener. Real-time updates on events, politics, business and more.
iCell Gene Therapeutics Announces Positive Clinical Data from Investigator Initiated Phase 1 Trial Evaluating BCMA-CD19 Compound CAR in Patients with Systemic Lupus Erythematosus/Lupus Nephritis Published in Annals of the Rheumatic Diseases
BCMA-CD19 compound CAR (cCAR) therapy was safe and well tolerated and achieved proof of concept of complete humoral reset delivering long-term medication-free remission - iCell's BCMA-CD19 cCAR
United States Greg Deener Yupo Ma University Shenzhen Hospital European Alliance Of Associations Lupus Foundation Of America
Source: finanznachrichten.de